Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab plus irinotecan and infusional 5-fluorouracil/folinic acid as first-line treatment for metastatic colorectal cancer
2004-004021-98Phase 4Completed
- Sponsor
- Roche
- Start
- Jun 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bevacizumab in colorectal cancer (CRC), sponsored by Roche. Started Jun 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2004-004021-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004021-98.